Cargando…
Experimental Evidence Shows Salubrinal, an eIF2α Dephosphorylation Inhibitor, Reduces Xenotoxicant-Induced Cellular Damage
Accumulating evidence indicates that endoplasmic reticulum (ER) stress and the subsequent unfolded protein response (UPR) are involved in the pathogenesis of not only the protein misfolding disorders such as certain neurodegenerative and metabolic diseases, but also in the cytotoxicity of environmen...
Autores principales: | Matsuoka, Masato, Komoike, Yuta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4519949/ https://www.ncbi.nlm.nih.gov/pubmed/26193263 http://dx.doi.org/10.3390/ijms160716275 |
Ejemplares similares
-
Salubrinal-Mediated Upregulation of eIF2α Phosphorylation Increases Doxorubicin Sensitivity in MCF-7/ADR Cells
por: Jeon, Yong-Joon, et al.
Publicado: (2016) -
Salubrinal protects against tunicamycin and hypoxia induced cardiomyocyte apoptosis via the PERK-eIF2α signaling pathway
por: Liu, Chun-Lei, et al.
Publicado: (2012) -
Salubrinal Regulates the Apoptosis of Adrenocortical Carcinoma Cells via the PERK/eIF2α/ATF4 Signaling Pathway
por: Wu, Lili, et al.
Publicado: (2021) -
Salubrinal protects cardiomyocytes against apoptosis in a rat myocardial infarction model via suppressing the dephosphorylation of eukaryotic translation initiation factor 2α
por: LI, RUI-JUN, et al.
Publicado: (2015) -
Inhibition of eIF2α dephosphorylation enhances TRAIL-induced apoptosis in hepatoma cells
por: Teng, Y, et al.
Publicado: (2014)